Belgium extends breast cancer screening:
This article was originally published in Clinica
Executive Summary
The Belgian government is allocating BFr480 million ($10 million) to extend its breast cancer screening programme to women aged between 50 and 69. Screening will begin in January and women of this age group will be tested every two years. A databank will be established to monitor the success of the scheme. Several other countries in Europe, including the UK, have recently extended breast cancer screening to older women than has traditionally been offered by the service. Spain is currently calling for screening for the group aged 45-50. News of the Belgian funding allocation has also sparked off a row over the role of mobile screening centres.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.